Alessandro Ucci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alessandro Ucci has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Antonio Freyrie
Department of Medicine and Surgery, Vascular Surgery, Parma University, Parma, Italy
9 shared publications- Paolo Perini
Vascular Surgery, Cardio-Thoracic and Vascular Department, University-Hospital of Parma, 43126 Parma, Italy
8 shared publications - Claudio Bianchini Massoni
Vascular Surgery, Cardio-Thoracic and Vascular Department, University Hospital of Parma, 43126 Parma, Italy
7 shared publications Matteo Azzarone
Department of Medicine and Surgery, University of Parma, Parma, Italy
6 shared publications- Giulia Rossi
Vascular Surgery, Department of Medicine and Surgery, University of Parma, Parma, Italy
5 shared publications Paolo Perini
Department of Medicine and Surgery, Vascular Surgery, Parma University, Parma, Italy
4 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 5 (8) , 105503
A Hemodynamic Scoring System for Optimizing Transcatheter Arterialization of the Deep Veins in No-Option Patients With Chronic Limb-Threatening Ischemia
- 30 June 2026
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 5 (8) , 105503
Open AccessA Hemodynamic Scoring System for Optimizing Transcatheter Arterialization of the Deep Veins in No-Option Patients With Chronic Limb-Threatening Ischemia
- 26 October 2025
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 33 (5) , 2621-2632
Patterns of Angiographic Remodeling Following Foot Vein Arterialization
Objective: Foot vein arterialization (FVA) in no-option patients with chronic limb-threatening ischemia (CLTI) provides promising rates of limb salvage and wound healing; however, the precise mechanisms underlying tissue perfusion after FVA are not fully understood. In most cases, FVA creates an arterialized circuit confined inside the foot vein fortress (FVF) upon initial completion. Over the following weeks to months, FVA facilitates a process of vascular remodeling leading to tissue perfusion. The primary objective of this study is to describe a novel classification system of the angiographic patterns of vascular remodeling observed in FVA and to hypothesize their pathophysiology and implications for limb salvage. Methods: This is a retrospective observational case series. We included no-option CLTI patients who underwent clinically-successful FVA (defined as achieving limb salvage with complete wound healing) and clinically-driven angiographic studies during follow-up. We identified 6 types of vascular remodeling: type 0, the arterialized circuit is confined inside the FVF; type 1, expansion of the arterialized circuit into venous systems outside the FVF; type 2, wound-related vascular remodeling leading to wound blush (WB); type 3, venous-arterial fistulas recruiting hibernated arterial segments; type 4, self-pruning of venous outflow; and type 5, promotion of collateral vessel growth with reconstitution of a new calf/foot distribution system. Results: Nineteen patients (12 with hybrid, and 7 with totally percutaneous FVA) were evaluated. The acute result of FVA showed a type 0 pattern in 13 patients (68.4%) and type 1 pattern in 6 (31.6%). During follow-up, patients required 43 new clinically-driven angiographic studies (mean 2.3/patient). The average time between initial FVA and subsequent angiographic studies was 164 ± 325.2 days (2-1895). In the 43 follow-up angiograms, the following pattern distribution was observed: type 0 pattern in 5 (11.6%), type 1 in 29 (67.4%), type 2 in 18 (41.9%), type 3 in 10 (23.3%), type 4 in 4 (9.3%), and type 5 in 7 (16.3%). Conclusion: Vascular remodeling after FVA is a complex process involving multiple pathophysiological mechanisms, resulting in various angiographic patterns. Recognizing these patterns may aid clinicians in developing targeted treatments to enhance FVA efficacy and improve clinical outcomes. Clinical Impact: This study introduces the first classification of angiographic patterns of vascular remodeling following foot vein arterialization (FVA), addressing the significant unpredictability of clinical outcomes despite high technical success in no-option CLTI patients. The primary clinical impact is providing a standardized framework to monitor and interpret the complex FVA maturation process. By recognizing the temporal evolution of these distinct patterns, clinicians can identify patients with suboptimal remodeling. This allows for targeted secondary interventions to guide vascular pathways, enhance tissue perfusion, and ultimately improve rates of wound healing and limb salvage, laying the groundwork for optimizing this limb-saving therapy.
- 26 October 2025
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 33 (5) , 2621-2632
Patterns of Angiographic Remodeling Following Foot Vein Arterialization
Objective: Foot vein arterialization (FVA) in no-option patients with chronic limb-threatening ischemia (CLTI) provides promising rates of limb salvage and wound healing; however, the precise mechanisms underlying tissue perfusion after FVA are not fully understood. In most cases, FVA creates an arterialized circuit confined inside the foot vein fortress (FVF) upon initial completion. Over the following weeks to months, FVA facilitates a process of vascular remodeling leading to tissue perfusion. The primary objective of this study is to describe a novel classification system of the angiographic patterns of vascular remodeling observed in FVA and to hypothesize their pathophysiology and implications for limb salvage. Methods: This is a retrospective observational case series. We included no-option CLTI patients who underwent clinically-successful FVA (defined as achieving limb salvage with complete wound healing) and clinically-driven angiographic studies during follow-up. We identified 6 types of vascular remodeling: type 0, the arterialized circuit is confined inside the FVF; type 1, expansion of the arterialized circuit into venous systems outside the FVF; type 2, wound-related vascular remodeling leading to wound blush (WB); type 3, venous-arterial fistulas recruiting hibernated arterial segments; type 4, self-pruning of venous outflow; and type 5, promotion of collateral vessel growth with reconstitution of a new calf/foot distribution system. Results: Nineteen patients (12 with hybrid, and 7 with totally percutaneous FVA) were evaluated. The acute result of FVA showed a type 0 pattern in 13 patients (68.4%) and type 1 pattern in 6 (31.6%). During follow-up, patients required 43 new clinically-driven angiographic studies (mean 2.3/patient). The average time between initial FVA and subsequent angiographic studies was 164 ± 325.2 days (2-1895). In the 43 follow-up angiograms, the following pattern distribution was observed: type 0 pattern in 5 (11.6%), type 1 in 29 (67.4%), type 2 in 18 (41.9%), type 3 in 10 (23.3%), type 4 in 4 (9.3%), and type 5 in 7 (16.3%). Conclusion: Vascular remodeling after FVA is a complex process involving multiple pathophysiological mechanisms, resulting in various angiographic patterns. Recognizing these patterns may aid clinicians in developing targeted treatments to enhance FVA efficacy and improve clinical outcomes. Clinical Impact: This study introduces the first classification of angiographic patterns of vascular remodeling following foot vein arterialization (FVA), addressing the significant unpredictability of clinical outcomes despite high technical success in no-option CLTI patients. The primary clinical impact is providing a standardized framework to monitor and interpret the complex FVA maturation process. By recognizing the temporal evolution of these distinct patterns, clinicians can identify patients with suboptimal remodeling. This allows for targeted secondary interventions to guide vascular pathways, enhance tissue perfusion, and ultimately improve rates of wound healing and limb salvage, laying the groundwork for optimizing this limb-saving therapy.
- 17 October 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 123, 454-465
Patterns of Arterial Obstruction in Chronic Limb-Threatening Ischemia: A Comprehensive Histopathological Analysis of Amputated Limbs
- 17 October 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 123, 454-465
Patterns of Arterial Obstruction in Chronic Limb-Threatening Ischemia: A Comprehensive Histopathological Analysis of Amputated Limbs
- 27 November 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 32 (5) , 1301-1316
Endovascular and Surgical Venous Arterialization for No-Option Patients With Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis
Background: Chronic limb-threatening ischemia (CLTI) is known for its high rates of major amputation and mortality. Conventional revascularization techniques often fail in CLTI patients due to the heavily diseased arteries. Foot vein arterialization (FVA) has been proposed as an alternative technique to provide arterial blood to the foot by using the disease-free venous bed. Objectives: This systematic review and meta-analysis aimed to determine outcomes of surgical FVA (sFVA) and percutaneous FVA (pFVA) at 6 and 12 months post-procedure. Data sources: PubMed, Scopus, Web of Science, and the Cochrane Library databases were searched to identify papers reporting clinical outcomes of sFVA and pFVA published between January 1966 and March 2023. Methods: Databases were searched for eligible studies. A meta-analysis was performed to evaluate the limb salvage rate, overall survival rate, and wound healing rate at 6 and 12 months. Results: A total of 27 studies were included, with 753 patients and 793 limbs. Of the included studies, 16 analyzed the sFVA technique and 11 the pFVA technique. Of the included patients, 86.3% were Rutherford 5/6 in the sFVA group versus 98.4% in the pFVA group. The pooled limb salvage rate at 6 and 12 months was 78.1% and 74.1% in the sFVA group and 81.7% and 78.6% in the pFVA group, respectively. Wound healing rates were not reported in the sFVA group. In the pFVA group, the pooled wound healing rates were 48.1% and 64.5% at 6 and 12 months, respectively. Conclusion: This study showed promising results after FVA among a large population of CLTI patients. In high-risk patients, pFVA is a feasible option with favorable limb salvage and wound healing rates.
- 27 November 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 32 (5) , 1301-1316
Endovascular and Surgical Venous Arterialization for No-Option Patients With Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis
Background: Chronic limb-threatening ischemia (CLTI) is known for its high rates of major amputation and mortality. Conventional revascularization techniques often fail in CLTI patients due to the heavily diseased arteries. Foot vein arterialization (FVA) has been proposed as an alternative technique to provide arterial blood to the foot by using the disease-free venous bed. Objectives: This systematic review and meta-analysis aimed to determine outcomes of surgical FVA (sFVA) and percutaneous FVA (pFVA) at 6 and 12 months post-procedure. Data sources: PubMed, Scopus, Web of Science, and the Cochrane Library databases were searched to identify papers reporting clinical outcomes of sFVA and pFVA published between January 1966 and March 2023. Methods: Databases were searched for eligible studies. A meta-analysis was performed to evaluate the limb salvage rate, overall survival rate, and wound healing rate at 6 and 12 months. Results: A total of 27 studies were included, with 753 patients and 793 limbs. Of the included studies, 16 analyzed the sFVA technique and 11 the pFVA technique. Of the included patients, 86.3% were Rutherford 5/6 in the sFVA group versus 98.4% in the pFVA group. The pooled limb salvage rate at 6 and 12 months was 78.1% and 74.1% in the sFVA group and 81.7% and 78.6% in the pFVA group, respectively. Wound healing rates were not reported in the sFVA group. In the pFVA group, the pooled wound healing rates were 48.1% and 64.5% at 6 and 12 months, respectively. Conclusion: This study showed promising results after FVA among a large population of CLTI patients. In high-risk patients, pFVA is a feasible option with favorable limb salvage and wound healing rates.
- 18 December 2021
- Published by SAGE Publications in Vascular
- Vol. 31 (1) , 98-106
Carotid endarterectomy in asymptomatic octogenarians: Outcomes at 30 days and 5 years
The following study investigated the 30-day and 5-year relative survival rate and freedom from neurological events in asymptomatic carotid stenosis (ACS) octogenarians who had undergone elective carotid endarterectomy (CEA). Between January 2008 and June 2014, a retrospective review was conducted on ACS patients who had undergone elective CEA. The patients’ sample was divided into two groups: Group A (GA) included octogenarians and Group B (GB) included younger patients. The GA patients were subjected to a risk-scoring system and follow-up. The two groups were compared analysing the following primary endpoints: 30-day mortality, stroke, stroke/death and acute myocardial infarction (AMI); GA patients’ survival rate and freedom from neurological events at 5 years. The 30-day secondary endpoints included carotid shunting, redo surgical, need for general anaesthesia with preserved consciousness (GAPC) conversion and length of hospital stay. We identified 620 patients with ACS, of them 144 (23.2%) belonged to the GA and 476 (76.8%) belonged to the GB. No statistical difference between the two groups was found regarding the primary and secondary endpoints. One hundred nineteen of 144 GA patients (82.6%) underwent the follow-up; the median follow-up was 78.3 months. The GA patients’ 5-year survival rate was 62%, while freedom from cerebral events was 94.9%. Analysis regarding GA patients’ 5-year survival rate revealed a significantly lower percentage among the patients with a severe risk score compared with those with a moderate risk score (respectively, 29.5% vs 67.7%; p = .005). The multivariate analysis showed that chronic obstructive pulmonary disease (COPD) and chronic kidney disease (CKD) were independently associated with lower survival. The 30-day outcomes of CEA in octogenarians are comparable to those in younger patients. Comprehensive life expectancy and preoperative score, rather than age alone, should be taken into account before performing CEA on octogenarian patients, considering the short- and long-term efficacy in stroke prevention.
- 18 December 2021
- Published by SAGE Publications in Vascular
- Vol. 31 (1) , 98-106
Carotid endarterectomy in asymptomatic octogenarians: Outcomes at 30 days and 5 years
The following study investigated the 30-day and 5-year relative survival rate and freedom from neurological events in asymptomatic carotid stenosis (ACS) octogenarians who had undergone elective carotid endarterectomy (CEA). Between January 2008 and June 2014, a retrospective review was conducted on ACS patients who had undergone elective CEA. The patients’ sample was divided into two groups: Group A (GA) included octogenarians and Group B (GB) included younger patients. The GA patients were subjected to a risk-scoring system and follow-up. The two groups were compared analysing the following primary endpoints: 30-day mortality, stroke, stroke/death and acute myocardial infarction (AMI); GA patients’ survival rate and freedom from neurological events at 5 years. The 30-day secondary endpoints included carotid shunting, redo surgical, need for general anaesthesia with preserved consciousness (GAPC) conversion and length of hospital stay. We identified 620 patients with ACS, of them 144 (23.2%) belonged to the GA and 476 (76.8%) belonged to the GB. No statistical difference between the two groups was found regarding the primary and secondary endpoints. One hundred nineteen of 144 GA patients (82.6%) underwent the follow-up; the median follow-up was 78.3 months. The GA patients’ 5-year survival rate was 62%, while freedom from cerebral events was 94.9%. Analysis regarding GA patients’ 5-year survival rate revealed a significantly lower percentage among the patients with a severe risk score compared with those with a moderate risk score (respectively, 29.5% vs 67.7%; p = .005). The multivariate analysis showed that chronic obstructive pulmonary disease (COPD) and chronic kidney disease (CKD) were independently associated with lower survival. The 30-day outcomes of CEA in octogenarians are comparable to those in younger patients. Comprehensive life expectancy and preoperative score, rather than age alone, should be taken into account before performing CEA on octogenarian patients, considering the short- and long-term efficacy in stroke prevention.
- Open Access
- 12 May 2021
- Vol. 92 (2) , e2021046
The Utility of Intraoperative Contrast-enhanced Ultrasound for Immediate Treatment of Type Ia Endoleak during EVAR: Initial Experience
Objectives Type Ia endoleak (EL) after endovascular abdominal aortic repair (EVAR) may be misdiagnosed at completion angiography. Intraoperative contrast-enhanced ultrasound (CEUS) may play a role in early detection and immediate treatment of type Ia EL. Methods From January 2017 to April 2018, patients treated with EVAR underwent intraoperative CEUS. After endograft deployment and ballooning, digital subtraction angiography (DSA) and intraoperative CEUS were performed in a blinded fashion. All cases of type Ia EL at DSA or CEUS were considered. Results Type Ia EL detected at intraoperative CEUS and undetected at DSA was defined in 2 patients. The former was solved with intraoperative re-ballooning; in the latter case, a Palmaz stent deployment was required. The resolution of type Ia EL was detected at intraoperative CEUS control and post-operative computed tomography angiography (CTA). In another patient, the DSA detected a type Ia EL, but intraoperative CEUS reveal a type II EL from lumbar arteries. Post-operative CTA confirm the type II EL. Conclusions The reported cases prove the clinical utility of the intraoperative CEUS, permitting the early identification of 2 type Ia EL. In addition, the intraoperative CEUS is useful in case of dubious type Ia EL at DSA, avoiding unnecessary intraoperative adjunctive procedure or post-operative CTA.
- 12 May 2021
- Vol. 92 (2) , e2021046
Open AccessThe Utility of Intraoperative Contrast-enhanced Ultrasound for Immediate Treatment of Type Ia Endoleak during EVAR: Initial Experience
Objectives Type Ia endoleak (EL) after endovascular abdominal aortic repair (EVAR) may be misdiagnosed at completion angiography. Intraoperative contrast-enhanced ultrasound (CEUS) may play a role in early detection and immediate treatment of type Ia EL. Methods From January 2017 to April 2018, patients treated with EVAR underwent intraoperative CEUS. After endograft deployment and ballooning, digital subtraction angiography (DSA) and intraoperative CEUS were performed in a blinded fashion. All cases of type Ia EL at DSA or CEUS were considered. Results Type Ia EL detected at intraoperative CEUS and undetected at DSA was defined in 2 patients. The former was solved with intraoperative re-ballooning; in the latter case, a Palmaz stent deployment was required. The resolution of type Ia EL was detected at intraoperative CEUS control and post-operative computed tomography angiography (CTA). In another patient, the DSA detected a type Ia EL, but intraoperative CEUS reveal a type II EL from lumbar arteries. Post-operative CTA confirm the type II EL. Conclusions The reported cases prove the clinical utility of the intraoperative CEUS, permitting the early identification of 2 type Ia EL. In addition, the intraoperative CEUS is useful in case of dubious type Ia EL at DSA, avoiding unnecessary intraoperative adjunctive procedure or post-operative CTA.
- Open Access
- 30 April 2021
- Vol. 92 (S1) , e2021149
Endovascular treatment for restenosis of carotid venous bypass graft: a clinical case report
Background and aim: Restenosis after open carotid surgery (OCS) represents an issue that experts are very often facing nowadays, both after carotid endoarterectomy(CEA) and carotid bypass(CB). Yet, even if from one side carotid artery stenting (CAS) is currently recommended by most guidelines as treatment of choice for carotid restenosis after CEA, on the other side little is known regarding the best treatment of restenosis after CB. This clinical case report is aimed to empathize the endovascular treatment as an effective therapeutic option for restenosis after OCS. Methods: A 75-year-old woman with severe comorbidities was admitted to our Unit for left carotid bypass graft restenosis. One year earlier, the patient had been treated with left carotid bypass grafting in saphenous vein for infectious complications occurred after CEA for symptomatic left carotid stenosis. The patient underwent a carotid Duplex ultrasonography scan (DUS) which showed a hemodynamically significant left carotid venous graft stenosis with peak systolic velocity of 315 cm/sec; in order to assess the grade of the stenosis a computed tomography angiography confirmed the presence of a significant narrowing of left carotid graft. A carotid artery angiography was performed after 20days, reconfirming the presence of a significant left carotid graft stenosis and was successfully treated with 7x40mm self-expanding stent. Results: The patient had an uneventful post-procedural course and was discharged the day after. After six months, the patient underwent a carotid DUS in our outpatient clinic which confirmed the overall graft and stent patency. Conclusion: CAS represents a feasible therapeutic option for carotid restenosis in patients treated after CB. This clinical case demonstrates that CAS can be performed with acceptable risks and good early results
- 30 April 2021
- Vol. 92 (S1) , e2021149
Open AccessEndovascular treatment for restenosis of carotid venous bypass graft: a clinical case report
Background and aim: Restenosis after open carotid surgery (OCS) represents an issue that experts are very often facing nowadays, both after carotid endoarterectomy(CEA) and carotid bypass(CB). Yet, even if from one side carotid artery stenting (CAS) is currently recommended by most guidelines as treatment of choice for carotid restenosis after CEA, on the other side little is known regarding the best treatment of restenosis after CB. This clinical case report is aimed to empathize the endovascular treatment as an effective therapeutic option for restenosis after OCS. Methods: A 75-year-old woman with severe comorbidities was admitted to our Unit for left carotid bypass graft restenosis. One year earlier, the patient had been treated with left carotid bypass grafting in saphenous vein for infectious complications occurred after CEA for symptomatic left carotid stenosis. The patient underwent a carotid Duplex ultrasonography scan (DUS) which showed a hemodynamically significant left carotid venous graft stenosis with peak systolic velocity of 315 cm/sec; in order to assess the grade of the stenosis a computed tomography angiography confirmed the presence of a significant narrowing of left carotid graft. A carotid artery angiography was performed after 20days, reconfirming the presence of a significant left carotid graft stenosis and was successfully treated with 7x40mm self-expanding stent. Results: The patient had an uneventful post-procedural course and was discharged the day after. After six months, the patient underwent a carotid DUS in our outpatient clinic which confirmed the overall graft and stent patency. Conclusion: CAS represents a feasible therapeutic option for carotid restenosis in patients treated after CB. This clinical case demonstrates that CAS can be performed with acceptable risks and good early results
- Open Access
- 29 December 2020
- Published by SAGE Publications in Vascular Medicine
- Vol. 26 (2) , 164-173
Association of infrapopliteal medial arterial calcification with lower-limb amputations in high-risk patients: A systematic review and meta-analysis
Medial arterial calcification (MAC) is a known risk factor for cardiovascular morbidity. The association between vascular calcifications and poor outcome in several vascular districts suggest that infrapopliteal MAC could be a risk factor for lower-limb amputation (LLA). This study’s objective is to review the available literature focusing on the association between infrapopliteal MAC and LLA in high-risk patients. The PubMed and Embase databases were systematically searched. We selected original studies reporting the association between infrapopliteal MAC and LLAs in patients with diabetes and/or peripheral artery disease (PAD). Estimates were pooled using either a fixed-effects or a random-effects model meta-analysis. Heterogeneity was evaluated using the Q and I2 statistics. Publication bias was investigated with a funnel plot and Egger test. The trim-and-fill method was designed to estimate the possibly missing studies. Influence analysis was conducted to search studies influencing the final result. Test of moderators was used to compare estimates in good versus non-good-quality studies. Fifteen articles satisfied the selection criteria ( n = 6489; median follow-up: 36 months). MAC was significantly associated with LLAs (pooled adjusted risk ratio (RR): 2.27; 95% CI: 1.89–2.74; I2 = 25.3%, Q-test: p = 0.17). This association was kept in the subgroup of patients with diabetes (RR: 2.37; 95% CI: 1.76–3.20) and patients with PAD (RR: 2.48; 95% CI: 1.72–3.58). The association was maintained if considering as outcome only major amputations (RR: 2.11; 95% CI: 1.46–3.06). Our results show that infrapopliteal MAC is associated with LLAs, thus suggesting MAC as a possible new marker of the at-risk limb.
- 29 December 2020
- Published by SAGE Publications in Vascular Medicine
- Vol. 26 (2) , 164-173
Open AccessAssociation of infrapopliteal medial arterial calcification with lower-limb amputations in high-risk patients: A systematic review and meta-analysis
Medial arterial calcification (MAC) is a known risk factor for cardiovascular morbidity. The association between vascular calcifications and poor outcome in several vascular districts suggest that infrapopliteal MAC could be a risk factor for lower-limb amputation (LLA). This study’s objective is to review the available literature focusing on the association between infrapopliteal MAC and LLA in high-risk patients. The PubMed and Embase databases were systematically searched. We selected original studies reporting the association between infrapopliteal MAC and LLAs in patients with diabetes and/or peripheral artery disease (PAD). Estimates were pooled using either a fixed-effects or a random-effects model meta-analysis. Heterogeneity was evaluated using the Q and I2 statistics. Publication bias was investigated with a funnel plot and Egger test. The trim-and-fill method was designed to estimate the possibly missing studies. Influence analysis was conducted to search studies influencing the final result. Test of moderators was used to compare estimates in good versus non-good-quality studies. Fifteen articles satisfied the selection criteria ( n = 6489; median follow-up: 36 months). MAC was significantly associated with LLAs (pooled adjusted risk ratio (RR): 2.27; 95% CI: 1.89–2.74; I2 = 25.3%, Q-test: p = 0.17). This association was kept in the subgroup of patients with diabetes (RR: 2.37; 95% CI: 1.76–3.20) and patients with PAD (RR: 2.48; 95% CI: 1.72–3.58). The association was maintained if considering as outcome only major amputations (RR: 2.11; 95% CI: 1.46–3.06). Our results show that infrapopliteal MAC is associated with LLAs, thus suggesting MAC as a possible new marker of the at-risk limb.
- 1 December 2020
- Published by Edizioni Minerva Medica in International Angiology
- Vol. 39 (6) , 477-484
Twelve years of experience in carotid endarterectomy with general anesthesia and preserved consciousness
Background: Carotid endarterectomy (CEA) can be performed both under general anesthesia (GA) or local anesthesia (LA) with good results. General anesthesia with preserved consciousness (GAPC) using remifentanil infusion has been already reported in literature and could potentially merge the advantages of GA and LA overcoming the disadvantages of this last technique. Although the good results of GAPC reported in literature, this technique is not widespread in clinical practice. The aim of this study was to report the perioperative results of CEA under GAPC in a large series of consecutive patients. Methods: This is a retrospective, single center, observational study including all patients treated for CEA under GAPC in our institution between January 2008 and October 2019. Primary endpoints were neurological complications rate, mortality rate in the perioperative period, need to GAPC conversion to GA during surgery and evaluation of the technique with a specific questionnaire regarding patients' satisfaction. Secondary endpoints were myocardial infarction (MI) rate, other perioperative complications rate, rate of intraoperative shunting and need of reintervention in the perioperative period. Results: In the considered period 1290 CEA under GAPC were performed and included in this study. Neurological complications rate was 2.01%, mortality rate in the perioperative period was 0.07%, need of GAPC conversion to GA rate during surgery was 0.46% and patients satisfaction regarding the technique were high with a mean vote of 9.1 in a 0 to 10 scale. In the perioperative period MI rate was 0.23%, other perioperative complications rate was 1.39%, intraoperative shunting rate was 7.1% and reintervention rate after surgery was 2.4%. Conclusions: CEA under GAPC may combine the advantages of LA and GA, with a very low rate of conversion to GA during surgery and good patients' satisfaction. Moreover, it does not increase neurological, cardiologic and systemic complications. For these reasons CEA under GAPC could represents a valid alternative to GA or LA.
- 1 December 2020
- Published by Edizioni Minerva Medica in International Angiology
- Vol. 39 (6) , 477-484
Twelve years of experience in carotid endarterectomy with general anesthesia and preserved consciousness
Background: Carotid endarterectomy (CEA) can be performed both under general anesthesia (GA) or local anesthesia (LA) with good results. General anesthesia with preserved consciousness (GAPC) using remifentanil infusion has been already reported in literature and could potentially merge the advantages of GA and LA overcoming the disadvantages of this last technique. Although the good results of GAPC reported in literature, this technique is not widespread in clinical practice. The aim of this study was to report the perioperative results of CEA under GAPC in a large series of consecutive patients. Methods: This is a retrospective, single center, observational study including all patients treated for CEA under GAPC in our institution between January 2008 and October 2019. Primary endpoints were neurological complications rate, mortality rate in the perioperative period, need to GAPC conversion to GA during surgery and evaluation of the technique with a specific questionnaire regarding patients' satisfaction. Secondary endpoints were myocardial infarction (MI) rate, other perioperative complications rate, rate of intraoperative shunting and need of reintervention in the perioperative period. Results: In the considered period 1290 CEA under GAPC were performed and included in this study. Neurological complications rate was 2.01%, mortality rate in the perioperative period was 0.07%, need of GAPC conversion to GA rate during surgery was 0.46% and patients satisfaction regarding the technique were high with a mean vote of 9.1 in a 0 to 10 scale. In the perioperative period MI rate was 0.23%, other perioperative complications rate was 1.39%, intraoperative shunting rate was 7.1% and reintervention rate after surgery was 2.4%. Conclusions: CEA under GAPC may combine the advantages of LA and GA, with a very low rate of conversion to GA during surgery and good patients' satisfaction. Moreover, it does not increase neurological, cardiologic and systemic complications. For these reasons CEA under GAPC could represents a valid alternative to GA or LA.
- 15 October 2020
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 28 (2) , 194-207
A Novel Scoring System for Small Artery Disease and Medial Arterial Calcification Is Strongly Associated With Major Adverse Limb Events in Patients With Chronic Limb-Threatening Ischemia
Purpose: To evaluate the roles of small artery disease (SAD) and medial arterial calcification (MAC) in patients with chronic limb-threatening ischemia (CLTI) and to identify any correlation between these factors and peripheral artery disease (PAD) or outcomes after treatment. Materials and Methods: A retrospective review was conducted of 259 limbs with tissue loss among 223 CLTI patients (mean age 72.2±11.4 years; 194 men) having an angiographic foot vessel study, foot radiography, and at least 6 months of follow-up after intervention. SAD and MAC were quantified using a 3-level score (0=absent, 1=moderate, 2=severe) based on angiography for SAD and foot radiographs for MAC. The MAC score was validated and compared with the SAD score, evaluating their associations with PAD distribution and clinical outcomes. Results: Based on the MAC score, the 259 limbs were classified as 55 group 0 (21.2%), 89 group 1 (34.4%), and 115 group 2 (44.4%). The SAD score stratified the 259 limbs as 67 group 0 (25.9%), 76 group 1 (29.3%), and 116 group 2 (44.8%). Interobserver reproducibility of the MAC score was high (correlation coefficient 0.96). Sensitivity and specificity of the MAC score in detecting SAD was 100% and 98.1%, respectively, in SAD groups 0 and 2 vs 99.1% and 92.7%, respectively, for SAD group 1. PAD was more proximal in MAC and SAD groups 0 and more distal in groups 1 and 2. Both MAC and SAD scores were able to predict clinical endpoints. Multivariable analysis demonstrated that the MAC score represents an independent risk factor for adverse limb events. Conclusion: SAD and MAC must be considered expressions of the same obstructing disease, able to adversely impact the fate of CLTI patients. SAD and MAC scores are powerful prognostic indicators of major adverse limb events in CLTI patients.
- 15 October 2020
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 28 (2) , 194-207
A Novel Scoring System for Small Artery Disease and Medial Arterial Calcification Is Strongly Associated With Major Adverse Limb Events in Patients With Chronic Limb-Threatening Ischemia
Purpose: To evaluate the roles of small artery disease (SAD) and medial arterial calcification (MAC) in patients with chronic limb-threatening ischemia (CLTI) and to identify any correlation between these factors and peripheral artery disease (PAD) or outcomes after treatment. Materials and Methods: A retrospective review was conducted of 259 limbs with tissue loss among 223 CLTI patients (mean age 72.2±11.4 years; 194 men) having an angiographic foot vessel study, foot radiography, and at least 6 months of follow-up after intervention. SAD and MAC were quantified using a 3-level score (0=absent, 1=moderate, 2=severe) based on angiography for SAD and foot radiographs for MAC. The MAC score was validated and compared with the SAD score, evaluating their associations with PAD distribution and clinical outcomes. Results: Based on the MAC score, the 259 limbs were classified as 55 group 0 (21.2%), 89 group 1 (34.4%), and 115 group 2 (44.4%). The SAD score stratified the 259 limbs as 67 group 0 (25.9%), 76 group 1 (29.3%), and 116 group 2 (44.8%). Interobserver reproducibility of the MAC score was high (correlation coefficient 0.96). Sensitivity and specificity of the MAC score in detecting SAD was 100% and 98.1%, respectively, in SAD groups 0 and 2 vs 99.1% and 92.7%, respectively, for SAD group 1. PAD was more proximal in MAC and SAD groups 0 and more distal in groups 1 and 2. Both MAC and SAD scores were able to predict clinical endpoints. Multivariable analysis demonstrated that the MAC score represents an independent risk factor for adverse limb events. Conclusion: SAD and MAC must be considered expressions of the same obstructing disease, able to adversely impact the fate of CLTI patients. SAD and MAC scores are powerful prognostic indicators of major adverse limb events in CLTI patients.